RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Clinical trials for RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM trials appear
Sign up with your email to follow new studies for RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to fight returning gynecologic cancers
Disease control OngoingThis study is testing an oral medication called tazemetostat for people whose ovarian or endometrial cancer has returned after previous treatments. The drug aims to stop cancer cell growth and shrink tumors. Researchers are enrolling 62 patients to see how well the treatment work…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists test Two-Drug attack on tough brain and solid tumors
Disease control OngoingThis early-stage study is testing the safety and best dose of a new oral drug, MLN0128, when given with the existing cancer drug bevacizumab. It is for adults with recurrent glioblastoma (a type of brain tumor) or other advanced solid tumors that have stopped responding to standa…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Three-Way drug fight against advanced uterine cancer
Disease control OngoingThis study aims to find the most effective drug combination for controlling advanced or recurrent endometrial cancer. It enrolled 349 patients to test three different mixes of chemotherapy and targeted therapy drugs. The goal is to see which combination best slows cancer growth a…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC